Clinical trials have been repeatedly shown to result not only in better future outcomes (including removal of failed interventions) but benefit the participants. Wonderful to be teaming up with @CDNCancerTrials @queensu

The Canadian Cancer Trials Group (#CCTG) is joining forces with @marathonofhope (#MOHCCN) to conduct three pan-Canadian projects with the goal of increasing the effectiveness of #immunotherapy for cancer patients. #CancerResearch #ClinicalTrials https://t.co/oQEgN9n2z4

Check out our latest preprint on MAPK-targeted therapies for patients with MAP2K1/MEK1 mutant cancers. Hopefully helpful for molecular tumor boards! @DrDrAprilRose @EmmaJRousselle @ANowakowski11 @annalazaratos @NicolaNormanno @ArielleElkrief @MLadanyi

This is a really cool study by Elena Kuzmin (@ElenaK35) and Morag Park, two fantastic colleagues in Montreal. Our (*now graduated) student Kento Abe @nbcc_ltri was able to provide interaction mapping for C4orf19, a new CCM3 (PDCD10) + kinase (GCKIII) interaction partner.

Absolutely thrilled & humbled to touch down in #Philadelphia to discover @ProfGLongMIA & I selected as joint nominee for NSW 2024 @ausoftheyear. Testament to our incredible @MelanomaAus team & selflessness of every patient & their family who contributes to our ongoing research.

I want to highlight a preprint from my colleagues, Boris Bastian and Dirk Hockemeyer, that unravels the mystery of the dysplastic nevus.

Excited to share our work “Insulin Receptor Loss Impairs Mammary Tumorigenesis in Mice“. Led by @LaurenMPodmore and @KatPlz, our study reveals a major function of INSR in breast/mammary tumour initiation, likely independent of its kinase activity. https://t.co/ErPwZ79ip2

His impact and legacy will forever inspire us. We will be honouring Dr. Jerry Pelletier's incredible legacy through various events and gatherings. Stay tuned for updates on how we will celebrate his life. Let's come together to commemorate a remarkable scientist and friend.

We are saddened to share the news that iconic McGill professor Jerry Pelletier has passed away. Our condolences to his family, friends and colleagues. Learn about his life and work in this profile from last year: https://t.co/AxcIQzrrUm

It is with heavy hearts that we share the passing of Dr. Jerry Pelletier, an esteemed alumnus of the Sonenberg lab and a pioneering figure in the field of mRNA translational control. He was more than a colleague; he was a cherished friend and mentor to many.

Adrian Thorogood is our Data Governance Manager. He met up with researchers from @IanWatsonLab at the run in Montreal!

Had a great #TerryFoxRun2023 in Montreal with the @IanWatsonLab and the members of the @McGillGCI ! What a lovely event to promote fundraising for cancer research. There is still time to donate at https://t.co/ZQwUy0kMYS

🚨 New funding announcement! 🚨 We're delighted to announce the winners of our inaugural MOHCCN Health Informatics & Data Science Awards! The recipients are eight promising, early-career data scientists in Ontario, Quebec and Nova Scotia More ▶️ https://t.co/dzuLMmytmQ (🧵)

“This study puts Canada at the forefront of microbiome research by showing we can safely improve patients’ response to immunotherapy through fecal transplants.” 🗨️ Dr. @BertrandRouty, MOHCCN Clinician-Scientist Learn more ▶️ https://t.co/PAkYnUXkNa

Claire’s talk was a highlight of this years Banff signalling meeting. Learn about adaptation of BioID for measuring signalling changes with 5 minute time slices. And she’s looking for an independent position.

A mind-blowing paper has come out today in @Nature In 2016, JC Venter Institute scientists trimmed a bacterial genome to its barest minimum required for life to synthesize what they called a "minimal genome" ( https://t.co/CNDeaZUmYd). Today, a group of scientists from

In patients with advanced #melanoma, fecal microbiota transplantation from healthy donors combined with anti-PD-1 #immunotherapy was well tolerated with a response rate of 65% in the first-line treatment setting @smimmunology @SchulichMedDentto https://t.co/OEz1ZLmPKD

Seven GCI scientists ranked top 100 in Canada for their disciplines: @SonenbergLab, Gros, Pelletier, @MoragPark1, Giguère, Tremblay & Yang We are privileged to have distinguished researchers who have influenced their fields of research to such extents https://t.co/D2yflCsmMJ

In 2016, I came up with a plan to change cancer patients' gut microbiome before immunotherapy. Now we have multiple trials doing that. Here are the results of the MIMic trial with the help of John Lenehan, @BertrandRouty, Mike Silverman, @Our_MicroBiome https://t.co/Hx3JpEOkjE

Press Release: New study published in @NatureComms identifies amino acid to potentially treat aggressive cancers https://t.co/MUDk1lhz48 Co-lead by Prof. Sidong Huang @HuangLabMcGill @McGillGCI and Prof. Yemin Wang @GCI_Cluster @bccancerfdn